High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
…, M Hanekom, HH Semvua… - The Lancet infectious …, 2017 - thelancet.com
Background Tuberculosis is the world's leading infectious disease killer. We aimed to
identify shorter, safer drug regimens for the treatment of tuberculosis. Methods We did a …
identify shorter, safer drug regimens for the treatment of tuberculosis. Methods We did a …
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
…, L Jugheli, N Sam, G Kibiki, H Semvua… - Journal of …, 2015 - academic.oup.com
Objectives SQ109, an asymmetrical diamine, is a novel anti-TB drug candidate. This first
study in patients was done to determine safety, tolerability, pharmacokinetics and …
study in patients was done to determine safety, tolerability, pharmacokinetics and …
Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania
Background Antiretroviral therapy (ART) has been shown to reduce HIV-related morbidity
and mortality amongst those living with HIV and reduce transmission of the virus to those who …
and mortality amongst those living with HIV and reduce transmission of the virus to those who …
Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania
AW Mbuya, IB Mboya, HH Semvua, SH Mamuya… - Plos one, 2023 - journals.plos.org
Tuberculosis (TB) is among diseases of global health importance with Sub Saharan Africa (SSA)
accounting for 25% of the global TB burden. TB prevalence among miners in SSA is …
accounting for 25% of the global TB burden. TB prevalence among miners in SSA is …
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settings
HH Semvua, GS Kibiki, ER Kisanga… - Therapeutic drug …, 2015 - journals.lww.com
Coadministration of antituberculosis and antiretroviral therapy is often inevitable in high-burden
countries where tuberculosis (TB) is the most common opportunistic infection associated …
countries where tuberculosis (TB) is the most common opportunistic infection associated …
COVID-19 knowledge, attitudes, practices and vaccination hesitancy in Moshi, Kilimanjaro Region, northern Tanzania
…, K Rwegoshola, O Balingumu, H Semvua… - Tanzania Journal of …, 2022 - ajol.info
Background: The COVID-19 vaccinations have reignited optimism in many cultures devastated
by the pandemic's tremendous loss of lives and livelihoods. Vaccination hesitancy is a …
by the pandemic's tremendous loss of lives and livelihoods. Vaccination hesitancy is a …
Clinical outcomes of new algorithm for diagnosis and treatment of tuberculosis sepsis in HIV patients
…, H Semvua, J Chilongola, S Semvua… - The International …, 2019 - journals.lww.com
Background: Despite effort to diagnose tuberculosis (TB) in the Human Immunodeficiency
Virus (HIV) infected population, 45% of adults with HIV that had a previously unknown reason …
Virus (HIV) infected population, 45% of adults with HIV that had a previously unknown reason …
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients
A Tostmann, CM Mtabho, HH Semvua… - Antimicrobial agents …, 2013 - Am Soc Microbiol
East Africa has a high tuberculosis (TB) incidence and mortality, yet there are very limited
data on exposure to TB drugs in patients from this region. We therefore determined the …
data on exposure to TB drugs in patients from this region. We therefore determined the …
Phenotypic changes on Mycobacterium tuberculosis-specific CD4 T cells as surrogate markers for tuberculosis treatment efficacy
…, NE Ntinginya, G Kibiki, BA Mtafya, H Semvua… - Frontiers in …, 2018 - frontiersin.org
Background: The analysis of phenotypic characteristics on Mycobacterium tuberculosis (MTB)-specific
T cells is a promising approach for the diagnosis of active tuberculosis (aTB) and …
T cells is a promising approach for the diagnosis of active tuberculosis (aTB) and …
Feasibility of real time medication monitoring among HIV infected and TB patients in a resource-limited setting
…, J van den Boogaard, KM Ngowi, HH Semvua… - AIDS and Behavior, 2016 - Springer
HIV infected and tuberculosis (TB) patients need high levels of treatment adherence to
achieve optimal treatment outcomes. We conducted a pilot-study on real time medication …
achieve optimal treatment outcomes. We conducted a pilot-study on real time medication …
